ArticleBMC cancer2022

Efficacy of platinum agents for stage III non-small-cell lung cancer following platinum-based chemoradiotherapy: a retrospective study.

Eriko Miyawaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.